Breaking News Instant updates and real-time market news.

MOMO

Hello Group

$16.90 /

+ (+0.00%)

, BMBL

Bumble

$74.61 /

-0.12 (-0.16%)

09:42
03/02/21
03/02
09:42
03/02/21
09:42

Benchmark sees 'hidden asset' inside Momo, ups target to $32

Benchmark analyst Fawne Jiang raised the firm's price target on Momo (MOMO) to $32 from $27 and keeps a Buy rating on the shares. The analyst views Momo's Tantan as "substantial, overlooked asset" in light of Bumble's (BMBL) recent initial public offering. The market seems to have overlooked the fundamental value proposition and the asset value of Tantan along with Momo "as a category leader in dating and stranger social network," Jiang tells investors in a research note. The analyst believes Momo's focus on retooling its user acquisition channels could potentially put Tantan's user growth "back on track later this year." Jiang sees "substantial upside" to Momo shares and calls Tantan a "hidden asset."

MOMO

Hello Group

$16.90 /

+ (+0.00%)

BMBL

Bumble

$74.61 /

-0.12 (-0.16%)

  • 10

    Mar

  • 11

    Feb

MOMO Hello Group
$16.90 /

+ (+0.00%)

12/02/20 Citi
Momo price target lowered to $16.10 from $20 at Citi
09/04/20
Fly Intel: Top five analyst initiations
09/04/20
Fly Intel: Top five analyst downgrades
09/04/20 86 Research
Momo initiated with a Buy at 86 Research
BMBL Bumble
$74.61 /

-0.12 (-0.16%)

TODAY'S FREE FLY STORIES

Earnings
Universal Display backs FY21 revenue view $530M-$560M, consensus $559.1M  16:09
08/05/21
08/05
16:09
08/05/21
16:09
OLED

Universal Display

$233.53 /

+1.87 (+0.81%)

 
ShowHide Related Items >><<
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

OLED Universal Display
$233.53 /

+1.87 (+0.81%)

05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
03/08/21 Evercore ISI
Evercore ISI 'emphatically' reiterates Outperform rating on Universal Display
03/08/21 Roth Capital
Universal Display upgraded to Buy at Roth Capital
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

Earnings
Beyond Meat reports Q2 EPS (31c), consensus (23c) » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
BYND

Beyond Meat

$122.62 /

-0.15 (-0.12%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

07/28/21 Piper Sandler
Synthetic biology a threat to Beyond Meat's 'ambition,' says Piper Sandler
06/23/21 JPMorgan
Beyond Meat breakfast sandwich discontinued at Dunkin', says JPMorgan
05/24/21
Fly Intel: Top five analyst upgrades
05/24/21 Bernstein
Beyond Meat upgraded to Outperform from Underperform at Bernstein
BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

Earnings
Catalyst Bancorp reports Q2 adjusted EPS (21c), consensus (19c) » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
CLST

Catalyst Bancorp

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Universal Display reports Q2 EPS $1.94, consensus 87c » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
OLED

Universal Display

$233.53 /

+1.87 (+0.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

OLED Universal Display
$233.53 /

+1.87 (+0.81%)

05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
03/08/21 Evercore ISI
Evercore ISI 'emphatically' reiterates Outperform rating on Universal Display
03/08/21 Roth Capital
Universal Display upgraded to Buy at Roth Capital
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

Hot Stocks
Novavax: Covid vaccine data shows increase in neutralizing antibody levels » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
NVAX

Novavax

$236.50 /

+12.7 (+5.67%)

Novavax announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

Earnings
Outset Medical reports Q2 EPS (57c), consensus (69c) » 16:08
08/05/21
08/05
16:08
08/05/21
16:08
OM

Outset Medical

$39.42 /

-1.48 (-3.62%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OM Outset Medical
$39.42 /

-1.48 (-3.62%)

OM Outset Medical
$39.42 /

-1.48 (-3.62%)

07/02/21 Stifel
Outset Medical CFO departure 'unexpected and surprising,' says Stifel
04/19/21 Wells Fargo
Outset Medical initiated with an Overweight at Wells Fargo
12/15/20 Oppenheimer
Oppenheimer starts Outset Medical at Perform, citing competition
12/15/20 Oppenheimer
Outset Medical initiated with a Perform at Oppenheimer
OM Outset Medical
$39.42 /

-1.48 (-3.62%)

  • 09
    Apr
  • 03
    Dec
  • 15
    Sep
OM Outset Medical
$39.42 /

-1.48 (-3.62%)

Earnings
Puma Biotechnology reports Q2 adjusted EPS 32c, consensus (34c) » 16:08
08/05/21
08/05
16:08
08/05/21
16:08
PBYI

Puma Biotechnology

$6.99 /

+0.13 (+1.90%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBYI Puma Biotechnology
$6.99 /

+0.13 (+1.90%)

PBYI Puma Biotechnology
$6.99 /

+0.13 (+1.90%)

12/24/20 Craig-Hallum
Celcuity price target raised to $19 from $16 at Craig-Hallum
PBYI Puma Biotechnology
$6.99 /

+0.13 (+1.90%)

Hot Stocks
Novavax, Serum Institute of India announce submission to regulators for vaccine » 16:08
08/05/21
08/05
16:08
08/05/21
16:08
NVAX

Novavax

$236.77 /

+12.97 (+5.80%)

Novavax, with its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

Hot Stocks
Outset Medical names Nabeel Ahmed as new CFO » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
OM

Outset Medical

$39.39 /

-1.51 (-3.69%)

Outset Medical announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OM Outset Medical
$39.39 /

-1.51 (-3.69%)

OM Outset Medical
$39.39 /

-1.51 (-3.69%)

07/02/21 Stifel
Outset Medical CFO departure 'unexpected and surprising,' says Stifel
04/19/21 Wells Fargo
Outset Medical initiated with an Overweight at Wells Fargo
12/15/20 Oppenheimer
Oppenheimer starts Outset Medical at Perform, citing competition
12/15/20 Oppenheimer
Outset Medical initiated with a Perform at Oppenheimer
OM Outset Medical
$39.39 /

-1.51 (-3.69%)

  • 09
    Apr
  • 03
    Dec
  • 15
    Sep
OM Outset Medical
$39.39 /

-1.51 (-3.69%)

Earnings
Dropbox reports Q2 EPS 40c, consensus 33c » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
DBX

Dropbox

$31.59 /

+0.155 (+0.49%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

06/10/21 RBC Capital
Dropbox assumed with an Outperform at RBC Capital
05/14/21 Goldman Sachs
Dropbox initiated with a Sell at Goldman Sachs
03/15/21 Jefferies
Dropbox price target raised to $31 from $28 at Jefferies
03/04/21 Citi
Citi adds Medallia to 'Value Creators' list, removes Dropbox
DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

Earnings
CarParts.com reports Q2 EPS 4c, consensus (4c) » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
PRTS

CarParts.com

$16.94 /

-0.18 (-1.05%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

02/16/21 Craig-Hallum
CarParts.com price target raised to $28 from $20 at Craig-Hallum
11/12/20 RBC Capital
RBC Capital starts CarParts.com at Outperform with $15 price target
11/12/20 RBC Capital
CarParts.com initiated with an Outperform at RBC Capital
09/09/20 Roth Capital
CarParts.com re-initiated with a Buy at Roth Capital
PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

  • 14
    Aug
PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

Earnings
Axonics raises FY21 revenue view to $186M-$188M, consensus $178.8MM » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
AXNX

Axonics

$63.05 /

-3.18 (-4.80%)

Prior guidance was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$63.05 /

-3.18 (-4.80%)

AXNX Axonics
$63.05 /

-3.18 (-4.80%)

07/16/21 Barclays
Axonics recall of Bulkamid is not material, says Barclays
07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Axonics initiated with an Overweight at Barclays
05/07/21 Piper Sandler
Axonics price target raised to $75 from $70 at Piper Sandler
AXNX Axonics
$63.05 /

-3.18 (-4.80%)

  • 12
    May
Earnings
Insulet backs FY21 revenue growth view 16%-20%, consensus $1.08B  16:07
08/05/21
08/05
16:07
08/05/21
16:07
PODD

Insulet

$280.60 /

+1.235 (+0.44%)

 
ShowHide Related Items >><<
PODD Insulet
$280.60 /

+1.235 (+0.44%)

PODD Insulet
$280.60 /

+1.235 (+0.44%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$280.60 /

+1.235 (+0.44%)

PODD Insulet
$280.60 /

+1.235 (+0.44%)

Earnings
Turtle Beach still sees 2021 revenue $385M, consensus $385.06M » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
HEAR

Turtle Beach

$28.70 /

-0.51 (-1.75%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
02/12/21 Maxim
Turtle Beach price target raised to $42 from $28 at Maxim
02/11/21 Stifel
Turtle Beach price target raised to $38 from $23.50 at Stifel
02/11/21 DA Davidson
Turtle Beach price target raised to $38 from $31 at DA Davidson
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

Earnings
Insulet sees Q3 revenue growth 11%-18%, consensus $274.16M  16:06
08/05/21
08/05
16:06
08/05/21
16:06
PODD

Insulet

$280.57 /

+1.205 (+0.43%)

 
ShowHide Related Items >><<
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

Earnings
Guardant Health sees FY21 revenue $360M-$370M, consensus $367.97M » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
GH

Guardant Health

$115.04 /

+1.24 (+1.09%)

Due to continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

GH Guardant Health
$115.04 /

+1.24 (+1.09%)

06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
06/03/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

  • 07
    Oct
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

Earnings
Axonics reports Q2 EPS (59c), consensus (49c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
AXNX

Axonics

$62.98 /

-3.25 (-4.91%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$62.98 /

-3.25 (-4.91%)

AXNX Axonics
$62.98 /

-3.25 (-4.91%)

07/16/21 Barclays
Axonics recall of Bulkamid is not material, says Barclays
07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Axonics initiated with an Overweight at Barclays
05/07/21 Piper Sandler
Axonics price target raised to $75 from $70 at Piper Sandler
AXNX Axonics
$62.98 /

-3.25 (-4.91%)

  • 12
    May
Earnings
Turtle Beach reports Q2 EPS 9c, consensus (10c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
HEAR

Turtle Beach

$28.70 /

-0.51 (-1.75%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
02/12/21 Maxim
Turtle Beach price target raised to $42 from $28 at Maxim
02/11/21 Stifel
Turtle Beach price target raised to $38 from $23.50 at Stifel
02/11/21 DA Davidson
Turtle Beach price target raised to $38 from $31 at DA Davidson
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

Earnings
Insulet reports Q2 EPS (37c), consensus 13c » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
PODD

Insulet

$280.57 /

+1.205 (+0.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

Earnings
Lionsgate reports Q1 adjusted EPS 18c, consensus (18c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
LGF.A

Lionsgate

$14.70 /

+0.36 (+2.51%)

, LGF.B

Lionsgate

$13.25 /

+0.36 (+2.79%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

07/22/21 Deutsche Bank
Lionsgate downgraded to Hold from Buy at Deutsche Bank
06/04/21 Barrington
Lionsgate price target raised to $27 from $16 at Barrington
06/01/21 Cowen
Lionsgate price target raised to $23 from $20 at Cowen
05/28/21 RBC Capital
Lionsgate price target raised to $17 from $13 at RBC Capital
LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

06/01/21 Cowen
Lionsgate price target raised to $23 from $20 at Cowen
05/28/21 RBC Capital
Lionsgate price target raised to $17 from $13 at RBC Capital
05/26/21 Truist
Amazon's MGM deal 'a very modest negative' for Netflix/Disney, says Truist
05/26/21 Loop Capital
Lionsgate price target raised to $21 from $16 at Loop Capital
LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

Earnings
Guardant Health reports Q2 adjusted EPS (61c), consensus (87c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
GH

Guardant Health

$115.04 /

+1.24 (+1.09%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

GH Guardant Health
$115.04 /

+1.24 (+1.09%)

06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
06/03/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

  • 07
    Oct
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

Upgrade
BCE upgraded to Buy from Hold at Canaccord » 16:05
08/05/21
08/05
16:05
08/05/21
16:05
BCE

BCE

$50.51 /

+0.78 (+1.57%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCE BCE
$50.51 /

+0.78 (+1.57%)

BCE BCE
$50.51 /

+0.78 (+1.57%)

08/04/21 TD Securities
BCE price target raised to C$66 from C$63 at TD Securities
05/03/21 Desjardins
BCE price target raised to C$62 from C$61 at Desjardins
04/30/21 Canaccord
BCE price target raised to C$59 from C$58 at Canaccord
04/30/21 RBC Capital
BCE price target raised to C$60 from C$59 at RBC Capital
BCE BCE
$50.51 /

+0.78 (+1.57%)

BCE BCE
$50.51 /

+0.78 (+1.57%)

BCE BCE
$50.51 /

+0.78 (+1.57%)

Earnings
Oncternal Therapeutics reports Q2 EPS (16c), consensus (14c) » 16:05
08/05/21
08/05
16:05
08/05/21
16:05
ONCT

Oncternal Therapeutics

$3.87 /

+0.13 (+3.48%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

04/06/21 Oppenheimer
Opco starts Oncternal at Outperform on 'compelling' lead asset data
04/06/21 Oppenheimer
Oncternal Therapeutics initiated with an Outperform at Oppenheimer
03/30/21
Fly Intel: Top five analyst initiations
03/30/21 Brookline
Oncternal Therapeutics initiated with a Buy at Brookline
ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

  • 18
    Nov
  • 28
    Aug
ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

Earnings
Apollo Investment reports Q2 EPS 49c, consensus 39c » 16:05
08/05/21
08/05
16:05
08/05/21
16:05
AINV

Apollo Investment

$13.69 /

+0.08 (+0.59%)

As of June 30, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AINV Apollo Investment
$13.69 /

+0.08 (+0.59%)

AINV Apollo Investment
$13.69 /

+0.08 (+0.59%)

05/24/21
Fly Intel: Top five analyst downgrades
05/24/21 Wells Fargo
Wells Fargo downgrades Apollo Investment with de-leveraging complete
05/24/21 Wells Fargo
Apollo Investment downgraded to Equal Weight from Overweight at Wells Fargo
11/10/20 Wells Fargo
Wells Fargo double upgrades Apollo Investment to Overweight on lower leverage
AINV Apollo Investment
$13.69 /

+0.08 (+0.59%)

Earnings
ViewRay sees 2021 revenue $63M-$73M, consensus $73.15M  16:05
08/05/21
08/05
16:05
08/05/21
16:05
VRAY

ViewRay

$6.89 /

+0.1 (+1.47%)

 
ShowHide Related Items >><<
VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
06/25/21 B. Riley
ViewRay announced 'most significant' purchase agreement, says B. Riley
06/14/21 Piper Sandler
ViewRay shares should attract more investor interest, says Piper Sandler
05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

  • 22
    Jan
  • 05
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.